Association between cell-derived microparticles and adverse events in patients with nonpulsatile left ventricular assist devices

Our results suggest that an elevation of PS+ microparticle levels may be associated with adverse clinical events. Thus, measuring PS+ microparticle levels in LVAD-supported patients may help identify patients at increased risk for adverse events.